FINDINGS OF SCIENTIFIC MISCONDUCT NIH GUIDE, Volume 24, Number 25, July 14, 1995 P.T. 34 Keywords: Ethics/Values in Science & Technol Grants Administration/Policy+ Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made final findings of scientific misconduct in the following cases: Gloria Clayton, R.N., Ed.D., Medical College of Georgia: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) reviewed an investigation report, forwarded by the Medical College of Georgia, into possible scientific misconduct on the part of Gloria Clayton, R.N., Ed.D., Professor of Adult Nursing at the Medical College of Georgia. ORI found that Dr. Clayton fabricated the existence of subjects and associated data under a subcontract with the Gerontology Center at the University of Georgia for research entitled \"Adaptation and Mental Health of the Oldest Old,\" supported by the National Institute of Mental Health. Dr. Clayton, who has admitted this fabrication, has accepted the ORI findings and agreed to a Voluntary Exclusion Agreement. Under the Agreement, Dr. Clayton is not eligible to apply for or receive any Federal grant or contract funds or to serve on any Public Health Service Advisory Committee, Board or peer review committee for a three-year period beginning May 25, 1995. In addition, Dr. Clayton has agreed to cooperate with the University of Georgia and the Medical College of Georgia in the submission of letters of correction to appropriate journals for publications shown to contain the fabricated data. Barbara Jones, St. Mary\'s Hospital, Montreal: The Office of Research Integrity (ORI) conducted an investigation into possible scientific misconduct on the part of Ms. Barbara Jones while a data coordinator at St. Mary\'s Hospital, Montreal, Quebec. ORI concluded that Ms. Jones committed scientific misconduct by falsifying and fabricating the dates of tests or examinations required prior to study entry for two women entered on the Breast Cancer Prevention Trial (BCPT). The BCPT is coordinated by the National Surgical Adjuvant Breast and Bowel Project (NSABP) and supported by the National Cancer Institute and the National Heart, Lung, and Blood Institute. Because the BCPT is still in progress, no conclusions or results have been published and no clinical recommendations have been based on the results of the study. Ms. Jones did not contest the ORI findings or administrative actions which require that, for a period of three years, any institution which proposes Ms. Jones\' participation in PHS-supported research must submit a supervisory plan designed to ensure the scientific integrity of her contribution. Ms. Jones is also prohibited from serving in any advisory capacity to the PHS for a period of three years. Farooq A. Siddiqui, Ph.D., Roswell Park Cancer Institute: The Division of Research Investigations (DRI) of the Office of Research Integrity (ORI) completed an investigation into possible scientific misconduct on the part of Dr. Siddiqui while he was an employee of Roswell Park Memorial Institute. ORI finds that Dr. Siddiqui committed scientific misconduct by misrepresenting data in a published article. The research was supported by a grant award from the National Cancer Institute, National Institutes of Health, Public Health Service (PHS). Dr. Siddiqui agreed not to appeal the misconduct finding as part of a Voluntary Settlement Agreement under which, for a period of two years, he will not apply as a principal or coprincipal investigator in any nonprocurement transactions (grants and cooperative agreements) or as a principal or coprincipal in any contract or subcontract with the United States Government. Dr. Siddiqui also is prohibited from serving on any Public Health Service advisory committee, board, and/or peer review committee for a period of two years. Also, for a two-year period the institution where he is employed will supervise his performance of work on any covered transaction including a periodic review of primary data, and certify the accuracy of any such data used in any United States Government Public Health Service grant application, contract proposal, or which is otherwise publicly reported. He has agreed to submit a letter to the journal Biochemica et Biophysica Acta (BBA) to retract the article entitled \"Purification and Immunological Characterization of DNA Polymerase-alpha from Human Acute Lymphoblastic Leukemia Cells\" (BBA, 745:154-161, 1983). INQUIRIES For further information, contact: Director Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330 .
